Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelReplace CC TiUltra RP 5.0x11.5mm: medical device reports filed with FDA

1,263 reports name it, 2021–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,263
device reports naming the brand
0% of all MAUDE reports · about 234 a year
340
reports, 12 months to August 2026
244 in the 12 months before
1.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,263 medical device reports received by FDA name the brand "NobelReplace CC TiUltra RP 5.0x11.5mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare; received from February 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

340 reports arrived in the 12 months to August 2026, up 39% from 244 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.7%) and malfunction (1.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (69.6%), loss of osseointegration (15.5%) and osseointegration problem (7%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03978Sep 2021: 12Oct 2021: 10Nov 2021: 8Dec 2021: 82022Jan 2022: 6Feb 2022: 16Mar 2022: 28Apr 2022: 18May 2022: 38Jun 2022: 10Jul 2022: 8Aug 2022: 8Sep 2022: 16Oct 2022: 8Nov 2022: 12Dec 2022: 72023Jan 2023: 14Feb 2023: 8Mar 2023: 22Apr 2023: 12May 2023: 30Jun 2023: 22Jul 2023: 12Aug 2023: 26Sep 2023: 24Oct 2023: 10Nov 2023: 34Dec 2023: 302024Jan 2024: 28Feb 2024: 24Mar 2024: 18Apr 2024: 36May 2024: 26Jun 2024: 8Jul 2024: 20Aug 2024: 16Sep 2024: 12Oct 2024: 30Nov 2024: 22Dec 2024: 142025Jan 2025: 32Feb 2025: 18Mar 2025: 12Apr 2025: 2May 2025: 0Jun 2025: 2Jul 2025: 78Aug 2025: 22Sep 2025: 34Oct 2025: 28Nov 2025: 16Dec 2025: 202026Jan 2026: 14Feb 2026: 34Mar 2026: 24Apr 2026: 30May 2026: 16Jun 2026: 26Jul 2026: 44Aug 2026: 54

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01322642021: 8420212022: 17520222023: 24420232024: 25420242025: 26420252026: 2422026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.7%1,246
Malfunction1.3%17
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%632
Voluntary report0%0
User facility report0%0
Distributor report50%631
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate87969.6%62.8%
Loss of osseointegration19615.5%22.4%
Osseointegration problem887%7.7%
Patient device interaction problem201.6%0.3%
Difficult to insertthe device was hard to insert141.1%0.4%
Insufficient device problem information80.6%0.2%
Device markings/labelling problema problem with the device markings or label60.5%0%
Migrationthe device moved from where it was placed60.5%0.1%
Activation, positioning or separation problem40.3%0%
Fracturea broken bone40.3%1.6%
Malposition of device40.3%0.1%
Contamination /decontamination problem20.2%0%
Material deformation20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant78562.2%
Painpain, site not specified735.8%
Numbnessnumbness181.4%
Abscessa collection of pus141.1%
Bone fracture(s)100.8%
Appropriate clinical signs, symptoms and conditions term/code not available80.6%
Inflammationinflammation80.6%
Implant pain60.5%
Fistula20.2%
Hypersensitivity/allergic reaction20.2%
Nerve damage20.2%
Sinus perforation20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelReplace CC TiUltra RP 5.0x11.5mmProduct code DZEAll MAUDE reports
Reports1,2633,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.7%99.2%36.2%
Classified as malfunction1.3%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelReplace CC TiUltra RP 5.0x11.5mm reports

How many FDA reports name NobelReplace CC TiUltra RP 5.0x11.5mm?

1,263 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 340 in the latest 12 months.

What kinds of events are reported?

injury (98.7%) and malfunction (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (69.6%), loss of osseointegration (15.5%), osseointegration problem (7%), patient device interaction problem (1.6%) and difficult to insert (1.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelReplace CC TiUltra RP 5.0x11.5mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.